Big Chemical Encyclopedia

Chemical substances, components, reactions, process design ...

Articles Figures Tables About

Pancreatic disorders

Other Inflammatory Muscle Disorders Endocrine Myopathies Thyroid Disorders Adrenal Disorders Pituitary Disorders Parathyroid Disorders Pancreatic Disorders Drug-Induced and Toxic Myopathies Management of Muscle Disease... [Pg.282]

PROBLEM 2.4 The isotope 34Se is used medically for diagnosis of pancreatic disorders. How many protons, neutrons, and electrons does an atom of 34Se have ... [Pg.47]

Erythromycin Erythromycin is incompatible with preparations that are highly acidic or alkaline in nature. Pancreatitis disorders are reported with erythromycin overdose. Erythromycin and other macrolides interact with other drugs and are detailed elsewhere.6... [Pg.335]

It wiU be evident from the section on processes of digestion and absorption that the pancreas plays a central role in the absorptive process for carbohydrates, fats, and proteins. Disorders of the exocrine pancreas are therefore frequently associated with GI symptoms of malabsorption or diarrhea. In this section, pediatric and adult exocrine pancreatic disorders are briefly discussed and tests for assessing exocrine pancreatic function are described. Information on exocrine pancreatic tumors can be found in the later section on GI regulatory peptides. Recent textbooks on gastroenterology or medicine have more detail on the clinical aspects of exocrine pancreatic disorders. [Pg.1867]

Pancreatic disorders in childhood have recently been reviewed and are summarized in Box 48-5. [Pg.1867]

The major exocrine pancreatic disorders presenting in adult life are acute pancreatitis, chronic pancreatitis, and carcinoma of the pancreas. The use of enzyme tests in the diagnosis of acute pancreatitis is discussed in Chapter 21. The etiologies of pancreatitis are given in Box 48-6. [Pg.1867]

Decreased CCK release decreased ionization of bile acids Deficiency of bile and pancreatic Disorders associated with mucosal... [Pg.219]

Pateints suffering from cancer, pancreatic disorders of anaemia... [Pg.222]

Pancreatic preparations have been widely used as digestive aids, because they contain proteases, amylase and lipase. They have been prescribed for patients who have pancreatic disorders or after removal of the pancreas. The various activities present in the pancreatic preparations can be duplicated by in vitro methods from blends of microbial enzymes derived from Bacillus subtilis, Aspergillus flavus-oryzae and Aspergillus niger. Cellulase derived from Aspergillus niger is often added to the microbial preparation. The pancreatic preparations still hold the major share of the market, but this could be a useful application for the right combination of microbial enzymes. [Pg.103]

Pancreatic disorders Hepatic disease Extrapancreatic tumors... [Pg.7]

CCK is found in the digestive tract and the central and peripheral nervous systems. In the brain, CCK coexists with DA. In the peripheral nervous system, the two principal physiological actions of CCK are stimulation of gaU. bladder contraction and pancreatic enzyme secretion. CCK also stimulates glucose and amino acid transport, protein and DNA synthesis, and pancreatic hormone secretion. In the CNS, CCK induces hypothermia, analgesia, hyperglycemia, stimulation of pituitary hormone release, and a decrease in exploratory behavior. The CCK family of neuropeptides has been impHcated in anxiety and panic disorders, psychoses, satiety, and gastric acid and pancreatic enzyme secretions. [Pg.539]

Type 2 diabetes is a heterogeneous and progressive endocrine disorder associated with insulin resistance (impaired insulin action) and defective function of the insulin-secreting (3-cells in the pancreatic islets of Langerhans. These endocrine disorders give rise to widespread metabolic disturbances epitomised by hyperglycaemia. The present classes of antidiabetic agents other than insulin act to either increase insulin secretion, improve insulin action, slow the rate of intestinal... [Pg.116]

Cystic fibrosis (CF) is a recessive genetic disorder prevalent among whites in North America and certain parts of northern Europe. It is characterized by chronic bacterial infections of the airways and sinuses, fat maldigestion due to pancreatic exocrine insufficiency, infertility in males due to abnormal development of the vas deferens, and elevated levels of chloride in sweat (> 60 mmol/L). [Pg.431]

Another condition involving ceruloplasmin is aceru-loplasminemia. in this genetic disorder, levels of ceruloplasmin are very low and consequently its ferroxidase activity is markedly deficient. This leads to failure of release of iron from cells, and iron accumulates in certain brain cells, hepatocytes, and pancreatic islet cells. Affected individuals show severe neurologic signs and have diabetes mellitus. Use of a chelating agent or administration of plasma or ceruloplasmin concentrate may be beneficial. [Pg.589]

Enhancement of the amylase creatinine clearance ratio in disorders other than acute pancreatitis. New Eng. J. Med. (1975), 329-332. [Pg.223]

Diabetes is a metabolic disorder where glucose metabolism in the body is impaired. Type 1 diabetes is an early onset disease in which the pancreatic cells lose the function of insulin secretion either by genetic disposition or by a viral attack. Type 2 diabetes is a late onset disease developed due to insufficient insulin secretion or insulin resistance resulting in impaired glucose metabolism. [Pg.367]

The neuropeptide Y (NPY) belongs to a family of peptides that includes peptide YY and pancreatic polypeptide, and it is associated with several diseases such as asthma, immune system disorders, inflammatory diseases, anxiety, depression and diabetes mellitus. NPY is found in the central and peripheral nervous system, and its biological functions are mediated by interactions with five receptor sub-types, i.e. Yl, Y2, Y4, Y5 and Y6. Several studies indicate that the feeding behavior is influenced by interactions between NPY and Yl and Y5. Deswal and Roy used Cerius descriptors and genetic function approximation QSAR to investigate the structural determinants for the inhibition potency of 24 compounds with the general structure 4 for the NPY Y5 receptor [31]. The best QSAR (H = 0.720,... [Pg.95]


See other pages where Pancreatic disorders is mentioned: [Pg.342]    [Pg.79]    [Pg.1869]    [Pg.1884]    [Pg.127]    [Pg.943]    [Pg.342]    [Pg.79]    [Pg.1869]    [Pg.1884]    [Pg.127]    [Pg.943]    [Pg.321]    [Pg.324]    [Pg.408]    [Pg.454]    [Pg.1231]    [Pg.231]    [Pg.231]    [Pg.636]    [Pg.199]    [Pg.71]    [Pg.183]    [Pg.361]    [Pg.179]    [Pg.245]    [Pg.415]    [Pg.57]    [Pg.17]    [Pg.3]   
See also in sourсe #XX -- [ Pg.342 ]




SEARCH



© 2024 chempedia.info